Use of ribose-cysteine to treat hypoxia by enhancing delivery of glutathione and ATP levels in cells
Details for Australian Patent Application No. 2005307885 (hide)
International Classifications
Event Publications
14 June 2007 PCT application entered the National Phase
PCT publication WO2006/055597 Priority application(s): WO2006/055597
28 June 2007 Amendment Made
The nature of the amendment is as shown in the statement(s) filed 23 May 2007
11 November 2010 Assignment before Grant
Bioceuticals, Inc. The application has been assigned to Max International, LLC
23 December 2010 Application Accepted
Published as AU-B-2005307885
21 April 2011 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser